Thomson Reuters Acquires GeneGo to Provide Pathway Analysis 'Complement' for Life Science Portfolio
December 03, 2010
Thomson Reuters Acquires GeneGo to Provide Pathway Analysis 'Complement' for Life Science Portfolio
According to the company, GeneGo's tools and expertise complement its life sciences portfolio and will provide its clients with a better understanding of underlying disease mechanisms, as well as potential therapies.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Linking Biomarkers to Pathway Analysis Marks First Step in Thomson Reuters, GeneGo Integration
May 6, 2011 / BioInform - TGen Heads NIH-funded $4.5M Brain Tumor Project
May 3, 2012 / GenomeWeb Daily News - Downloads and Upgrades
August 12, 2011 / BioInform - Thomson Reuters Buys GeneGo
November 30, 2010 / GenomeWeb Daily News - GeneGo, Omicsoft Combine MetaCore and Array Studio for Deeper NGS Data Analysis
October 1, 2010 / BioInform